Advanced Medical Solutions Group (LON:AMS) Releases Earnings Results

Advanced Medical Solutions Group (LON:AMS) released its quarterly earnings data on Wednesday. The company reported GBX 11.98 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Advanced Medical Solutions Group had a net margin of 4.16% and a return on equity of 3.69%.

Advanced Medical Solutions Group Trading Up 2.0%

LON AMS opened at GBX 200.65 on Wednesday. The firm’s fifty day moving average price is GBX 212.98 and its 200 day moving average price is GBX 214.50. Advanced Medical Solutions Group has a 12 month low of GBX 168.40 and a 12 month high of GBX 248.50. The company has a debt-to-equity ratio of 32.15, a current ratio of 2.88 and a quick ratio of 4.58. The company has a market capitalization of £434.18 million, a price-to-earnings ratio of 48.12, a price-to-earnings-growth ratio of 5.00 and a beta of 0.60.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research report on Thursday, January 15th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of GBX 273.67.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.